| 2023 | 2022 | 2021 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,6 M € | -64.0% | 15,6 M € | +19.2% | 13,1 M € | +145.0% | 5,4 M € | +16.3% | 4,6 M € | -22.1% | 5,9 M € | -48.7% | 11,5 M € | — | — | 4,9 M € | — | — | — | — | ||||||||
| Gross margin | — | — | — | — | — | — | — | 4,3 M € | +24.6% | 3,4 M € | +22.1% | 2,8 M € | +83.9% | 1,5 M € | +40.6% | 1,1 M € | +39.1% | 778,2 k € | +7.2% | 726,1 k € | ||||||||
| EBITDA | -5,4 M € | -566.7% | 1,2 M € | -43.4% | 2,0 M € | +272.1% | 547,7 k € | +9.6% | 499,9 k € | -29.9% | 713,2 k € | -3.1% | 736,2 k € | -34.5% | 1,1 M € | +16.9% | 961,7 k € | -26.3% | 1,3 M € | +150.4% | 521,1 k € | +43.3% | 363,5 k € | +71.7% | 211,8 k € | -43.4% | 374,4 k € | |
| Operating profit | -5,4 M € | -1174.5% | 504,6 k € | -46.5% | 943,4 k € | +153.0% | 372,9 k € | +32.7% | 281,1 k € | -40.6% | 473,5 k € | +63.2% | 290,2 k € | -58.4% | 697,0 k € | +24.9% | 557,9 k € | -44.5% | 1,0 M € | +227.6% | 306,6 k € | +297.1% | 77,2 k € | -8.4% | 84,2 k € | -69.0% | 271,6 k € | |
| Profit/loss | -3,5 M € | -715.4% | 575,8 k € | -83.6% | 3,5 M € | +1460.5% | 224,5 k € | +260.0% | -140,3 k € | -205.0% | 133,6 k € | -14.0% | 155,4 k € | -68.3% | 490,6 k € | +0.6% | 487,7 k € | -35.5% | 756,3 k € | +234.0% | 226,5 k € | +482.5% | 38,9 k € | -36.2% | 61,0 k € | -67.0% | 184,9 k € | |
| Equity | 34,2 M € | +205.3% | 11,2 M € | +5.4% | 10,6 M € | +240.9% | 3,1 M € | +7.8% | 2,9 M € | -4.6% | 3,0 M € | +4.6% | 2,9 M € | +14.0% | 2,5 M € | +23.9% | 2,0 M € | +31.2% | 1,6 M € | +93.9% | 805,7 k € | +39.1% | 579,2 k € | +7.2% | 540,4 k € | +10.7% | 488,2 k € | |
| Total assets | 52,2 M € | +117.5% | 24,0 M € | +11.7% | 21,5 M € | +293.1% | 5,5 M € | +19.8% | 4,6 M € | -3.9% | 4,7 M € | -11.9% | 5,4 M € | +37.7% | 3,9 M € | +1.1% | 3,9 M € | +55.9% | 2,5 M € | +66.2% | 1,5 M € | +22.7% | 1,2 M € | +44.7% | 841,0 k € | -5.5% | 889,9 k € | |
| Cash | 5,0 M € | +26.8% | 4,0 M € | +101.0% | 2,0 M € | +544.2% | 306,6 k € | -60.4% | 774,1 k € | -4.4% | 809,8 k € | -46.0% | 1,5 M € | +50.1% | 998,1 k € | +79.8% | 555,2 k € | +35.9% | 408,6 k € | +189.0% | 141,4 k € | +29.3% | 109,4 k € | -11.4% | 123,4 k € | -24.7% | 163,9 k € | |
| Debts | 17,6 M € | +39.6% | 12,6 M € | +21.9% | 10,3 M € | +377.2% | 2,2 M € | +35.6% | 1,6 M € | -5.7% | 1,7 M € | -31.7% | 2,5 M € | +81.1% | 1,4 M € | -24.6% | 1,8 M € | +97.5% | 921,1 k € | +33.9% | 687,9 k € | +8.2% | 635,6 k € | +112.1% | 299,7 k € | -25.4% | 401,6 k € | |
| Staff | 31,6 | 31,6 | 37,8 | 14,1 | 12,1 | 24,5 | 45 | 44,7 | 37,5 | 25,2 | 16,7 | 13,7 | 11,2 | 7,2 | ||||||||||||||
Public limited company · Antwerpen · incorporated on 18/05/2005 · 31,6 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+26.8%).
Solid counterparty for a standard engagement.
IQVIA MedTech NV is a Public limited company incorporated in 2005. Its main activity is: Technical testing and analysis. Its registered office is in Antwerpen. It employs on average 31,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette